Literature DB >> 17015476

Phosphorylation of Chk1 by ATR is antagonized by a Chk1-regulated protein phosphatase 2A circuit.

Van Leung-Pineda1, Christine E Ryan, Helen Piwnica-Worms.   

Abstract

In higher eukaryotic organisms, the checkpoint kinase 1 (Chk1) contributes essential functions to both cell cycle and checkpoint control. Chk1 executes these functions, in part, by targeting the Cdc25A protein phosphatase for ubiquitin-mediated proteolysis. In response to genotoxic stress, Chk1 is phosphorylated on serines 317 (S317) and 345 (S345) by the ataxia-telangiectasia-related (ATR) protein kinase. Phosphorylation of Chk1 on these C-terminal serine residues is used as an indicator of Chk1 activation in vivo. Here, we report that inhibition of Chk1 kinase activity paradoxically leads to the accumulation of S317- and S345-phosphorylated Chk1 in vivo and that ATR catalyzes Chk1 phosphorylation under these conditions. We demonstrate that Chk1 phosphorylation by ATR is antagonized by protein phosphatase 2A (PP2A). Importantly, dephosphorylation of Chk1 by PP2A is regulated, in part, by the kinase activity of Chk1. We propose that the ATR-Chk1-PP2A regulatory circuit functions to keep Chk1 in a low-activity state during an unperturbed cell division cycle but at the same time keeps Chk1 primed to respond rapidly in the event that cells encounter genotoxic stress.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17015476      PMCID: PMC1636880          DOI: 10.1128/MCB.00447-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  53 in total

1.  DNA-PKcs function regulated specifically by protein phosphatase 5.

Authors:  Thomas Wechsler; Benjamin P C Chen; Ryan Harper; Keiko Morotomi-Yano; Betty C B Huang; Katheryn Meek; James E Cleaver; David J Chen; Matthias Wabl
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-20       Impact factor: 11.205

2.  Requirement of protein phosphatase 5 in DNA-damage-induced ATM activation.

Authors:  Ambereen Ali; Ji Zhang; Shideng Bao; Irene Liu; Diane Otterness; Nicholas M Dean; Robert T Abraham; Xiao-Fan Wang
Journal:  Genes Dev       Date:  2004-02-01       Impact factor: 11.361

3.  The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01.

Authors:  P R Graves; L Yu; J K Schwarz; J Gales; E A Sausville; P M O'Connor; H Piwnica-Worms
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

4.  Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice.

Authors:  H Takai; K Tominaga; N Motoyama; Y A Minamishima; H Nagahama; T Tsukiyama; K Ikeda; K Nakayama; M Nakanishi; K Nakayama
Journal:  Genes Dev       Date:  2000-06-15       Impact factor: 11.361

5.  Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.

Authors:  Q Liu; S Guntuku; X S Cui; S Matsuoka; D Cortez; K Tamai; G Luo; S Carattini-Rivera; F DeMayo; A Bradley; L A Donehower; S J Elledge
Journal:  Genes Dev       Date:  2000-06-15       Impact factor: 11.361

6.  Requirement for Atr in phosphorylation of Chk1 and cell cycle regulation in response to DNA replication blocks and UV-damaged DNA in Xenopus egg extracts.

Authors:  Z Guo; A Kumagai; S X Wang; W G Dunphy
Journal:  Genes Dev       Date:  2000-11-01       Impact factor: 11.361

7.  Differential mode of regulation of the checkpoint kinases CHK1 and CHK2 by their regulatory domains.

Authors:  Chuen-Pei Ng; Hung Chiu Lee; Chung Wai Ho; Talha Arooz; Wai Yi Siu; Anita Lau; Randy Y C Poon
Journal:  J Biol Chem       Date:  2003-12-16       Impact factor: 5.157

8.  PP1 control of M phase entry exerted through 14-3-3-regulated Cdc25 dephosphorylation.

Authors:  Seth S Margolis; Susan Walsh; Douglas C Weiser; Minoru Yoshida; Shirish Shenolikar; Sally Kornbluth
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

9.  Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding.

Authors:  Mei-Shya Chen; Christine E Ryan; Helen Piwnica-Worms
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

10.  Recovery from DNA damage checkpoint arrest by PP1-mediated inhibition of Chk1.

Authors:  Nicole R den Elzen; Matthew J O'Connell
Journal:  EMBO J       Date:  2004-02-05       Impact factor: 11.598

View more
  84 in total

Review 1.  What goes on must come off: phosphatases gate-crash the DNA damage response.

Authors:  Dong-Hyun Lee; Dipanjan Chowdhury
Journal:  Trends Biochem Sci       Date:  2011-09-18       Impact factor: 13.807

2.  Pot1 and cell cycle progression cooperate in telomere length regulation.

Authors:  Dmitri Churikov; Carolyn M Price
Journal:  Nat Struct Mol Biol       Date:  2007-12-09       Impact factor: 15.369

Review 3.  Turning off the G2 DNA damage checkpoint.

Authors:  Teresa M Calonge; Matthew J O'Connell
Journal:  DNA Repair (Amst)       Date:  2007-09-11

4.  A role for Chk1 in blocking transcriptional elongation of p21 RNA during the S-phase checkpoint.

Authors:  Rachel Beckerman; Aaron J Donner; Melissa Mattia; Melissa J Peart; James L Manley; Joaquin M Espinosa; Carol Prives
Journal:  Genes Dev       Date:  2009-06-01       Impact factor: 11.361

5.  A Role for the Twins Protein Phosphatase (PP2A-B55) in the Maintenance of Drosophila Genome Integrity.

Authors:  Chiara Merigliano; Antonio Marzio; Fioranna Renda; Maria Patrizia Somma; Maurizio Gatti; Fiammetta Vernì
Journal:  Genetics       Date:  2016-12-30       Impact factor: 4.562

6.  Role of Chk1 in the differentiation program of hematopoietic stem cells.

Authors:  Laura Carrassa; Elisa Montelatici; Lorenza Lazzari; Stefano Zangrossi; Matteo Simone; Massimo Broggini; Giovanna Damia
Journal:  Cell Mol Life Sci       Date:  2010-02-10       Impact factor: 9.261

7.  Cyclin A/Cdk2 regulates Cdh1 and claspin during late S/G2 phase of the cell cycle.

Authors:  Vanessa Oakes; Weili Wang; Brittney Harrington; Won Jae Lee; Heather Beamish; Kee Ming Chia; Alex Pinder; Hidemasa Goto; Masaki Inagaki; Sandra Pavey; Brian Gabrielli
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

8.  Checkpoint kinase 2 is required for efficient immunoglobulin diversification.

Authors:  Kathrin Davari; Samantha Frankenberger; Angelika Schmidt; Nils-Sebastian Tomi; Berit Jungnickel
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

9.  LY2603618, a selective CHK1 inhibitor, enhances the anti-tumor effect of gemcitabine in xenograft tumor models.

Authors:  Darlene Barnard; H Bruce Diaz; Teresa Burke; Gregory Donoho; Richard Beckmann; Bonita Jones; David Barda; Constance King; Mark Marshall
Journal:  Invest New Drugs       Date:  2015-11-27       Impact factor: 3.850

10.  Regulation of chk1.

Authors:  Claudia Tapia-Alveal; Teresa M Calonge; Matthew J O'Connell
Journal:  Cell Div       Date:  2009-04-29       Impact factor: 5.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.